SCHEMBL18955464

SCHEMBL18955464

Cc1cccc(F)c1NC(=O)C(=O)Nc1c(C)cccc1F

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48
KMT2A Q03164 2/20 0.46
NLRP3 Q96P20 1/20 0.45
MEN1 O00255 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2C9 P11712 1/20 0.44
NFKB1 P19838 1/20 0.44
CYP2C19 P33261 1/20 0.44
CHRNA7 P36544 2/20 0.44
KDM4E B2RXH2 1/20 0.44
POLB P06746 3/20 0.43
ACHE P22303 1/20 0.43
HDAC3 O15379 1/20 0.42
HDAC4 P56524 1/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC7 Q8WUI4 1/20 0.42
HDAC2 Q92769 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20194482 0.98 ALDH1A1 (0.53) ALDH1A1L3MBTL1NPC1RAB9AKMT2A
SCHEMBL28921103 0.89 ALDH1A1 (0.49) ALDH1A1L3MBTL1NPC1RAB9AKMT2A
SCHEMBL3598057 0.86 ALDH1A1 (0.50) ALDH1A1L3MBTL1KMT2ANLRP3MEN1
SCHEMBL6430240 0.85 ALDH1A1 (0.70) ALDH1A1L3MBTL1NPC1RAB9AKMT2A
SCHEMBL18415481 0.85 KMT2A (0.59) ALDH1A1NPC1RAB9AKMT2ANLRP3
SCHEMBL19781758 0.83 NLRP3 (0.53) ALDH1A1L3MBTL1KMT2ANLRP3MEN1
SCHEMBL17845245 0.82 LMNA (0.49) ALDH1A1L3MBTL1KMT2ANLRP3MEN1
SCHEMBL20362848 0.82 PDK1 (0.50) ALDH1A1L3MBTL1RAB9AKMT2ANLRP3
SCHEMBL26409973 0.82 KMT2A (0.52) ALDH1A1NPC1RAB9AKMT2ANLRP3
SCHEMBL25249826 0.80 ALDH1A1 (0.50) ALDH1A1L3MBTL1NLRP3CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4431180-A2 OLEFIN METATHESIS CATALYSTS Umicore AG & Co. KG (DE) 2024-09-18 EP disclosed
US-20210053043-A1 OLEFIN METATHESIS CATALYSTS CALIFORNIA INSTITUTE OF TECHNOLOGY 2021-02-25 US disclosed
US-20210053043-A1 OLEFIN METATHESIS CATALYSTS CALIFORNIA INSTITUTE OF TECHNOLOGY 2021-02-25 US disclosed
US-10857530-B2 Olefin metathesis catalysts UMICORE AG & CO. KG (DE) 2020-12-08 US disclosed
US-10857530-B2 Olefin metathesis catalysts UMICORE AG & CO. KG (DE) 2020-12-08 US disclosed
US-20180361371-A1 OLEFIN METATHESIS CATALYSTS UMICORE AG & CO KG (DE) 2018-12-20 US disclosed
EP-3386936-A1 OLEFIN METATHESIS CATALYSTS Umicore AG & Co. KG (DE) 2018-10-17 EP disclosed
WO-2017100585-A1 OLEFIN METATHESIS CATALYSTS MATERIA, INC. (US) 2017-06-15 WO disclosed
WO-2017100585-A1 OLEFIN METATHESIS CATALYSTS MATERIA, INC. (US) 2017-06-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10857530-B2 Olefin metathesis catalysts ZDHHC7, ZDHHC2, OSBP ALDH1A1 1629/4885L3MBTL1 774/4885NPC1 891/4885
US-20210053043-A1 OLEFIN METATHESIS CATALYSTS ZDHHC7, ZDHHC2, OSBP ALDH1A1 1629/4885L3MBTL1 774/4885NPC1 891/4885
US-20180361371-A1 OLEFIN METATHESIS CATALYSTS ZDHHC7, ZDHHC2, OSBP ALDH1A1 1629/4885L3MBTL1 774/4885NPC1 891/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.